Published: August 30, 2026 · Last updated: September 2, 2026
Cellular senescence, explained
Scientific review: This article is reviewed with doctoral-level scientific oversight.
Evidence standard: Human, animal, and laboratory findings are distinguished throughout.
Read our Editorial & Research Standards →
Zombie cells are senescent cells—living cells that have stopped dividing but remain metabolically active. Senescence can serve useful biological functions, but some senescent cells may persist and accumulate with age.
Why would a cell stop dividing?
Cells can enter senescence after significant stress or damage. It is not simply a sign that a cell has failed. Senescence can be part of normal biology, including a protective response that helps stop damaged cells from multiplying and can contribute to wound repair.
Why are scientists interested?
With aging and in certain biological settings, senescent cells can accumulate. Some release a mixture of signaling molecules that may affect nearby tissue and inflammation. Researchers are working to identify the many different forms of senescence across the human body and to understand when these cells are helpful, harmful, or both.
That is why this field has become so compelling: it connects fundamental cell biology with big questions about how the body changes over time.
What “zombie cells” does not mean
It is a useful metaphor, not a medical diagnosis. Researchers do not have a routine consumer test that can tell an individual how many senescent cells they have or whether they need a particular intervention. The science is active, evolving, and more nuanced than a simple “good cells versus bad cells” story.
What happens inside a senescent cell?
Cellular senescence is more than simply a cell becoming old. It is a biological response in which a cell enters a durable state of growth arrest. The cell generally stops dividing, but it can remain alive and metabolically active.
Researchers have identified several features that can accompany cellular senescence. These may include changes in gene activity, altered metabolism, mitochondrial dysfunction, persistent DNA-damage signaling and increased activity of cell-cycle regulators such as p16 and p21.
However, there is no single feature that identifies every senescent cell. The exact pattern can vary depending on the tissue, cell type and type of stress that caused the cell to become senescent.
Why can senescent cells become a problem?
Senescence can be useful when it occurs temporarily. For example, it can help prevent damaged cells from continuing to divide and can participate in tissue repair and wound healing.
Problems may arise when senescent cells persist instead of being removed. Some senescent cells release signaling molecules, inflammatory factors and other substances into their surrounding environment. Researchers collectively refer to this activity as the senescence-associated secretory phenotype, or SASP.
The SASP can influence nearby cells, immune activity and tissue function. Its effects are not universally harmful, but persistent SASP signaling is one reason scientists are studying the possible connection between accumulating senescent cells, chronic inflammation and age-related tissue dysfunction.
Learn more about the SASP and how senescent cells can affect nearby tissue →
Do zombie cells accumulate as we age?
Evidence from human and animal research indicates that senescent cells become more common in many tissues with increasing age. This does not mean that every older person has the same amount or type of cellular senescence.
Senescent-cell accumulation may reflect a combination of increased cellular damage, more cells entering senescence and reduced ability of the immune system to identify and clear some senescent cells.
Researchers are now mapping these cells across human tissues to understand where they occur, how they differ and which forms of senescence may be associated with healthy or unhealthy aging.
See what the research shows about zombie cells and aging →
Scientists are discovering different types of zombie cells
One of the most important developments in cellular-senescence research is the realization that senescent cells are not all alike.
Scientists increasingly use the term senotype to describe different patterns of senescence. A senescent immune cell may behave differently from a senescent cell in the lung, skin, fat tissue or brain.
In 2026, researchers supported by the National Institutes of Health Cellular Senescence Network reported a large-scale framework for identifying and cataloging senescent cells across the human body. The work showed substantial variation among senescent cells depending on cell type, tissue and biological environment.
This matters because a treatment that affects one type of senescent cell may not necessarily affect another type in the same way.
Explore the Human Senescence Atlas and how researchers are mapping these cells →
How do scientists identify senescent cells?
There is currently no single universal test that can identify every senescent cell throughout the human body.
Researchers typically look for combinations of biological signals. These may include increased p16 or p21 activity, changes in cell proliferation, senescence-associated beta-galactosidase activity, DNA-damage markers, SASP molecules and patterns of gene or protein expression.
Newer research also uses single-cell sequencing, spatial biology and other molecular technologies to distinguish different senescent-cell populations.
Because these markers vary between tissues and circumstances, researchers generally rely on multiple measurements rather than treating one marker as definitive proof of senescence.
Learn how scientists test for cellular senescence →
What causes cells to become senescent?
Many different forms of cellular stress can trigger senescence. These include DNA damage, telomere dysfunction, oxidative stress, mitochondrial problems, oncogene activation and tissue injury. Some cancer treatments can also induce cellular senescence.
The response is often protective at first because preventing a severely damaged cell from continuing to divide can reduce the risk of uncontrolled growth.
The biological consequences depend heavily on what happens afterward — particularly whether the senescent cell is successfully cleared or remains in the tissue for a prolonged period.
Read the complete guide to what causes zombie cells →
Why are researchers studying senolytics?
Because persistent senescent cells may contribute to some age-related changes, researchers are investigating compounds known as senolytics. The goal of senolytic research is to determine whether certain compounds can selectively eliminate particular senescent cells while leaving healthy cells relatively unaffected.
Much of the strongest evidence for senolytic effects still comes from laboratory and animal studies. Early human studies exist, but they do not yet establish that senolytic compounds broadly slow human aging, extend lifespan or safely remove senescent cells throughout the body.
The increasing recognition that different senotypes exist makes this question even more complex. A compound showing activity against one senescent cell type cannot automatically be assumed to work against every senescent cell.
Read our introduction to senolytics and the evidence behind them →
Are all zombie cells bad?
No. Cellular senescence is part of normal biology.
Senescence can help suppress tumor formation by preventing damaged cells from continuing to divide. Senescent cells can also participate in wound healing, tissue remodeling and other short-term biological processes.
The scientific concern is therefore not simply whether senescent cells exist. Researchers are trying to understand when senescence is beneficial, when persistent cells become detrimental and whether particular senescent-cell populations can eventually be targeted safely.
Learn why senescent cells are not always harmful →
What scientists still do not know
Cellular senescence is an active and rapidly developing area of research. Important unanswered questions remain, including:
- Which senescent-cell populations contribute most strongly to specific age-related diseases?
- Which biomarkers best identify harmful senescence in humans?
- How effectively does the immune system remove different senescent cells?
- Can harmful senescent cells be targeted without disrupting beneficial forms of senescence?
- Which experimental senolytic approaches, if any, will produce meaningful long-term benefits in humans?
These uncertainties are important. Discoveries in mice, cell cultures or early-stage human trials should not automatically be interpreted as evidence that eliminating senescent cells will slow aging in otherwise healthy people.
The takeaway
Senescent cells are real, scientifically important, and under intense study. The most responsible way to follow this emerging field is to look at the quality of the evidence, distinguish laboratory findings from proven human outcomes, and keep learning as clinical research develops.
Read the source material
- NIH Common Fund: Cellular Senescence Network (SenNet)
- NIH (2026): New framework for identifying and cataloging senescent cells
- NIH (2026): Senescent cells mapped in the human body over the lifespan
- Suryadevara et al. (2026): Charting human cellular senescence in aging and disease
- Wang et al. (2024): The senescence-associated secretory phenotype and its physiological and pathological implications
- Review (2024): The role of p21 in cellular senescence and aging-related disease
Educational information only; not medical advice.
Explore more source-backed guides in the Research Library →
